A Phase 1b Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study Assessing the PK, Pharmacodynamics, Safety, and Tolerability of SB414 in Subjects With Psoriasis

Trial Profile

A Phase 1b Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study Assessing the PK, Pharmacodynamics, Safety, and Tolerability of SB414 in Subjects With Psoriasis

Completed
Phase of Trial: Phase I

Latest Information Update: 15 May 2018

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Psoriasis
  • Focus Pharmacokinetics
  • Sponsors Novan Inc
  • Most Recent Events

    • 15 May 2018 According to a Novan Inc media release, PK and PD data analysis from this trial is ongoing.
    • 26 Mar 2018 Status changed from active, no longer recruiting to completed.
    • 19 Feb 2018 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top